Systematic review newer inactivated seasonal influenza vaccine

With this project, ECDC would like to conduct a systematic review, assessment and synthesis of the evidence in the literature on safety, efficacy and effectiveness of newer inactivated seasonal influenza vaccines (egg-based MF-59 adjuvanted seasonal influenza vaccine, egg-based high-dose seasonal influenza vaccine, cell-based seasonal influenza vaccine, cell-based recombinant HA seasonal influenza vaccine) in individuals ≥18 years of age.